Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma

British Journal of Cancer

Volumn 111, Issue 8, 2014, Pages 1526-1531

  Hofbauer, S L ^a   Stangl, K I ^a   De Martino, M ^a   Lucca, I ^a,b   Haitel, A ^a   Shariat, S F ^a   Klatte, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; TUMOR MARKER;

AGED; BLOOD; ENZYMOLOGY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; CARCINOMA, RENAL CELL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84908869538     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.450     Document Type: Article

References (33)

1. Corti A, Franzini M, Paolicchi A, Pompella A (2010) Gammaglutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res 30: 1169-1181.
2. de Martino M, Hoetzenecker K, Ankersmit HJ, Roth GA, Haitel A, Waldert M, Klatte T (2012a) Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis. Br J Cancer 106: 904-908.
3. de Martino M, Klatte T, Haitel A, Marberger M (2012b) Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. Cancer 118: 82-90.
4. de Martino M, Klatte T, Seemann C, Waldert M, Haitel A, Schatzl G, Remzi M, Weibl P (2013) Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). BJU Int 111: E348-E353.
5. Ficarra V, Martignoni G, Lohse C, Novara G, Pea M, Cavalleri S, Artibani W (2006) External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 175: 1235-1239.
6. Fischer P, Scherberich JE (1996) Hybridomas reveal shared immunodominant epitopes of gamma-glutamyltransferase isoforms from human kidney and renal cell carcinoma. Tumour Biol 17: 369-377.
7. Fischer P, Störkel S, Haase W, Scherberich JE (1991) Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against gamma-glutamyltransferase. Cancer Immunol Immunother 33: 382-388.
8. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168: 2395-2400.
9. Grimm C, Hofstetter G, Aust S, Mutz-Dehbalaie I, Bruch M, Heinze G, Rahhal-Schupp J, Reinthaller A, Concin N, Polterauer S (2013) Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer 109: 610-614.
10. Hanigan MH, Frierson HF (1996) Immunohistochemical detection of gammaglutamyl transpeptidase in normal human tissue. J Histochem Cytochem 44: 1101-1108.
11. Hanigan MH, Ricketts WA (1993) Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 32: 6302-6306.
12. Heng DYC, XieW, ReganMM, Harshman LC, Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan M-H, Rha S-Y, Agarwal N, Kollmannsberger C, Rini BI, Choueiri TK (2013) External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol 14: 141-148.
13. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
14. Kaufmann O, Dietel M, Scherberich JE, Gaedicke G, Fischer P (1997) Immunohistochemical differentiation of metastases of renal carcinomas versus other carcinomas with anti-gamma GT monoclonal antibody 138H11. Histopathology 31: 31-37.
15. Kroeger N, Xie W, Lee J-L, Bjarnason GA, Knox JJ, Mackenzie MJ, Wood L, Srinivas S, Vaishamayan UN, Rha S-Y, Pal SK, Yuasa T, Donskov F, Agarwal N, Kollmannsberger CK, Tan M-H, North SA, Rini BI, Choueiri TK, Heng DYC (2013) Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer 119: 2999-3006.
16. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133.
17. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard J-J, Mulders PFA, Sinescu IC (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58: 398-406.
18. Lusini L, Tripodi SA, Rossi R, Giannerini F, Giustarini D, del Vecchio MT, Barbanti G, Cintorino M, Tosi P, Di Simplicio P (2001) Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int J Cancer 91: 55-59.
19. Mazumdar M, Glassman JR (2000) Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decisionmaking about cancer treatments. Stat Med 19: 113-132.
20. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391.
21. Pastore A, Federici G, Bertini E, Piemonte F (2003) Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 333: 19-39.
22. Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R (2013) High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer 109: 1123-1129.
23. Polterauer S, Hofstetter G, Grimm C, Rahhal J, Mailath-Pokorny M, Kohl M, Concin N, Tempfer C, Marth C, Reinthaller A (2011) Relevance of gamma-glutamyltransferase-a marker for apoptotic balance-in predicting tumor stage and prognosis in cervical cancer. Gynecol Oncol 122: 590-594.
24. Procopio G, Verzoni E, Iacovelli R, Biasoni D, Testa I, Porcu L, De Braud F (2012) Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies. Br J Cancer 107: 1227-1232.
25. Ramankulov A, Lein M, Kristiansen G, Meyer H-A, Loening SA, Jung K (2007) Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma. J Cancer Res Clin Oncol 133: 643-652.
26. Russo A, DeGraff W, Friedman N, Mitchell JB (1986) Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46: 2845-2848.
27. Sandock DS, Seftel AD, Resnick MI (1997) The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma. J Urol 157: 798-799.
28. Schiele F, Guilmin AM, Detienne H, Siest G (1977) Gammaglutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem 23: 1023-1028.
29. Seebacher V, Polterauer S, Grimm C, Rahhal J, Hofstetter G, Bauer E-M, Husslein H, Leipold H, Marth C, Reinthaller A, Concin N (2012) Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial. Br J Cancer 106: 1551-1555.
30. Simic T, Dragicevic D, Savic-Radojevic A, Cimbaljevic S, Tulic C, Mimic-Oka J (2007) Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma. Int J Urol 14: 289-293.
31. Strasak AM, Goebel G, Concin H, Pfeiffer RM, Brant LJ, Nagel G, OberaignerW, Concin N, Diem G, Ruttmann E, Gruber-Moesenbacher U, Offner F, Pompella A, Pfeiffer KP, Ulmer H (2010) Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer. Cancer Res 70: 3586-3593.
32. Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38: 263-355.
33. Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS (2002) Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20: 4559-4566.